9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
34 hedge funds and large institutions have $2.08M invested in 9 Meters Biopharma in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 8 closing their positions.
13% less funds holding
Funds holding: 39 → 34 (-5)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
53% less capital invested
Capital invested by funds: $4.4M → $2.08M (-$2.32M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15.1K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$12.2K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$4.42K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.5K |
| 5 |
Renaissance Technologies
New York
|
+$756 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$57.7K |
| 2 |
HF
HRT Financial
New York
|
-$25K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$22.6K |
| 4 |
Millennium Management
New York
|
-$21K |
| 5 |
Mercer Global Advisors
Denver,
Colorado
|
-$14K |
NMTR Hedge Fund Activity: Q2 2023 in Review
34 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q2 2023, worth a combined $2.08M — down 53% from $4.4M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of NMTR and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $15.1K. The largest seller was Sabby Management, cutting an estimated $57.7K.
- 34 institutional investors held 9 Meters Biopharma (NMTR) as of Q2 2023, down from 39 in Q1 2023.
- Funds reported $2.08M of 9 Meters Biopharma stock for Q2 2023, down 53% quarter-over-quarter.
- 3 funds opened new 9 Meters Biopharma positions in Q2 2023 and 8 closed out, a net change of -5 holders.
- The largest 9 Meters Biopharma buyer in Q2 2023 was Susquehanna International Group, an estimated $15.1K added.
- The largest 9 Meters Biopharma seller in Q2 2023 was Sabby Management, an estimated $57.7K sold.
Based on aggregated 13F filings for Q2 2023.